3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Wilms Tumor
1
Testicular Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Congenital Abnormalities
1
Interventions
Peripheral Blood Stem Cell Transplantation
41
fludarabine phosphate
33
Cyclophosphamide
31
Mycophenolic Acid
25
Whole-Body Irradiation
22
Cyclosporine
22
Busulfan
21
Tacrolimus
20
Antilymphocyte Serum
17
Methotrexate
16
Filgrastim
14
Etoposide
12
Radiotherapy
11
Psychiatric Rehabilitation
11
Melphalan
11
Methylprednisolone
10
Flow Cytometry
10
Therapeutics
9
Polymerase Chain Reaction
8
Gemcitabine
8
Rituximab
7
sargramostim
6
Vorinostat
6
Sirolimus
6
Cord Blood Stem Cell Transplantation
6
Transplantation
5
Nivolumab
5
Dexamethasone
5
Calcium Dobesilate
5
Bortezomib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Lithium Carbonate
×
Dermatologic
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts